Literature DB >> 27757474

Minocycline affects human neutrophil respiratory burst and transendothelial migration.

Astrid Parenti1, Boris Indorato1, Sara Paccosi2.   

Abstract

OBJECTIVE: This study aimed at investigating the in vitro activity of minocycline and doxycycline on human polymorphonuclear (h-PMN) cell function.
METHODS: h-PMNs were isolated from whole venous blood of healthy subjects; PMN oxidative burst was measured by monitoring ROS-induced oxidation of luminol and transendothelial migration was studied by measuring PMN migration through a monolayer of human umbilical vein endothelial cells. Differences between multiple groups were determined by ANOVA followed by Tukey's multiple comparison test; Student's t test for unpaired data for two groups.
RESULTS: Minocycline (1-300 µM) concentration dependently and significantly inhibited oxidative burst of h-PMNs stimulated with 100 nM fMLP. Ten micromolar concentrations, which are superimposable to C max following a standard oral dose of minocycline, promoted a 29.8 ± 4 % inhibition of respiratory burst (P < 0.001; n = 6). Doxycycline inhibited ROS production with a lesser extent and at higher concentrations. 10-100 µM minocycline impaired PMN transendothelial migration, with maximal effect at 100 µM (42.5 ± 7 %, inhibition, n = 5, P < 0.001).
CONCLUSIONS: These results added new insight into anti-inflammatory effects of minocycline exerted on innate immune h-PMN cell function.

Entities:  

Keywords:  Inflammation; Minocycline; Neutrophils; ROS; Transendothelial migration

Mesh:

Substances:

Year:  2016        PMID: 27757474     DOI: 10.1007/s00011-016-0999-x

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  15 in total

1.  Minocycline ameliorates LPS-induced inflammation in human monocytes by novel mechanisms including LOX-1, Nur77 and LITAF inhibition.

Authors:  Tao Pang; Juan Wang; Julius Benicky; Juan M Saavedra
Journal:  Biochim Biophys Acta       Date:  2012-01-27

Review 2.  Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines.

Authors:  Kenneth N Agwuh; Alasdair MacGowan
Journal:  J Antimicrob Chemother       Date:  2006-07-01       Impact factor: 5.790

3.  The effect of antimicrobial agents on leukocyte chemotaxis.

Authors:  N B Esterly; N L Furey; L E Flanagan
Journal:  J Invest Dermatol       Date:  1978-01       Impact factor: 8.551

4.  Inhibition of human neutrophil oxidative burst by pyrazolone derivatives.

Authors:  David Costa; Alexandra P Marques; Rui L Reis; José L F C Lima; Eduarda Fernandes
Journal:  Free Radic Biol Med       Date:  2005-10-21       Impact factor: 7.376

5.  Minocycline modulates neuroinflammation independently of its antimicrobial activity in staphylococcus aureus-induced brain abscess.

Authors:  Tammy Kielian; Nilufer Esen; Shuliang Liu; Nirmal K Phulwani; Mohsin M Syed; Napoleon Phillips; Koren Nishina; Ambrose L Cheung; Joseph D Schwartzman; Jorg J Ruhe
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

Review 6.  Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs.

Authors:  L M Golub; N S Ramamurthy; T F McNamara; R A Greenwald; B R Rifkin
Journal:  Crit Rev Oral Biol Med       Date:  1991

7.  Minocycline attenuates nitric oxide-mediated neuronal and axonal destruction in vitro.

Authors:  Alastair Wilkins; Maria Nikodemova; Alastair Compston; Ian Duncan
Journal:  Neuron Glia Biol       Date:  2004-08

8.  MCP-induced protein 1 mediates the minocycline-induced neuroprotection against cerebral ischemia/reperfusion injury in vitro and in vivo.

Authors:  Zhuqing Jin; Jian Liang; Jing Wang; Pappachan E Kolattukudy
Journal:  J Neuroinflammation       Date:  2015-02-27       Impact factor: 8.322

9.  Doxycycline impairs neutrophil migration to the airspaces of the lung in mice exposed to intratracheal lipopolysaccharide.

Authors:  Andres Moon; Sucheol Gil; Sean E Gill; Peter Chen; Gustavo Matute-Bello
Journal:  J Inflamm (Lond)       Date:  2012-09-03       Impact factor: 4.981

10.  Minocycline prevents retinal inflammation and vascular permeability following ischemia-reperfusion injury.

Authors:  Steven F Abcouwer; Cheng-Mao Lin; Sumathi Shanmugam; Arivalagan Muthusamy; Alistair J Barber; David A Antonetti
Journal:  J Neuroinflammation       Date:  2013-12-10       Impact factor: 8.322

View more
  1 in total

Review 1.  Revisiting Minocycline in Intracerebral Hemorrhage: Mechanisms and Clinical Translation.

Authors:  Ruiyi Zhang; V Wee Yong; Mengzhou Xue
Journal:  Front Immunol       Date:  2022-03-17       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.